VOYA Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-27,747
| Closed | -$311K | – | 2637 |
|
|
2017
Q3 | $311K | Hold |
27,747
| – | – | ﹤0.01% | 2153 |
|
|
2017
Q2 | $305K | Buy |
27,747
+3,157
| +13% | +$31.6K | ﹤0.01% | 2152 |
|
|
2017
Q1 | $241K | Hold |
24,590
| – | – | ﹤0.01% | 2182 |
|
|
2016
Q4 | $266K | Hold |
24,590
| – | – | ﹤0.01% | 2137 |
|
|
2016
Q3 | $252 | Sell |
24,590
-3,113
| -11% | -$33.9K | ﹤0.01% | 2148 |
|
|
2016
Q2 | $362K | Hold |
27,703
| – | – | ﹤0.01% | 1912 |
|
|
2016
Q1 | $305K | Hold |
27,703
| – | – | ﹤0.01% | 1985 |
|
|
2015
Q4 | $255K | Hold |
27,703
| – | – | ﹤0.01% | 2156 |
|
|
2015
Q3 | $192K | Sell |
27,703
-9,197
| -25% | -$78.8K | ﹤0.01% | 2285 |
|
|
2015
Q2 | $362K | Hold |
36,900
| – | – | ﹤0.01% | 2143 |
|
|
2015
Q1 | $327K | Hold |
36,900
| – | – | ﹤0.01% | 2180 |
|
|
2014
Q4 | $323K | Hold |
36,900
| – | – | ﹤0.01% | 2213 |
|
|
2014
Q3 | $254K | Hold |
36,900
| – | – | ﹤0.01% | 2366 |
|
|
2014
Q2 | $194K | Hold |
36,900
| – | – | ﹤0.01% | 2576 |
|
|
2014
Q1 | $168K | Hold |
36,900
| – | – | ﹤0.01% | 2522 |
|
|
2013
Q4 | $186K | Hold |
36,900
| – | – | ﹤0.01% | 2499 |
|
|
2013
Q3 | $187K | Hold |
36,900
| – | – | ﹤0.01% | 2503 |
|
|
2013
Q2 | $183K | Buy |
+36,900
| New | +$176K | ﹤0.01% | 2525 |
|
VOYA Investment Management's SCLN Position: Q4 2017 in Review
VOYA Investment Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 27,747 shares — an estimated $311K sold.
VOYA Investment Management first reported a position in SCLN in Q2 2013 and held it in 18 quarters. The position peaked at $362K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.
- VOYA Investment Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
- VOYA Investment Management sold 27,747 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $311K.
- VOYA Investment Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
- VOYA Investment Management's Sciclone Pharmaceuticals Inc position peaked at $362K in Q2 2016.
- 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.
Based on VOYA Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.